9amHealth
PrivateLast Round
Series B
May 13, 2026
Est. Valuation
$155M
Total Funding Raised
$55.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
9amHealth operates in Healthcare & Life Sciences and is based in Encinitas, California. Its latest recorded funding round was a Series B round in May 2026.
9amHealth is a virtual specialty care company that provides an integrated platform for managing cardiometabolic conditions such as obesity, diabetes, hypertension, and high cholesterol.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
9amHealth Comparables
Compare 9amHealth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Form Health | 87% | |
| FlyteHealth | 84% | |
| Calibrate | 84% |
For institutional investors. Book with your work email.
9amHealth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2026 | ||||
| Early Stage VC | Mar 16, 2026 | ||||
| Series A Extension | Feb 20, 2024 | ||||
| Series A | Apr 13, 2022 | ||||
| Seed | Sep 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
9amHealth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series A, Series A Extension |
| Define Ventures | Series A, Series A Extension, Seed, Series B |
| 7wire Ventures | Series B, Series A Extension, Series A |
| Cigna Ventures | Series B |
| Founders Fund | Series A, Series A Extension, Seed |
| Catalio Capital Management | Series B |
| Speedinvest | Series A Extension, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
Launched an autoimmune care program with a new Medical Director hire.
- Sep 24, 2026
Grew 16% QoQ, adding 27 employees.
For institutional investors. Book with your work email.
9amHealth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 9amHealth's valuation, stock price, and market status.
Is 9amHealth a public or private company?
9amHealth is a private company.
What is the current stock price of 9amHealth?
9amHealth is a private company, so its shares have no public market price. Caplight tracks 9amHealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 9amHealth worth (valuation)?
9amHealth's valuation is estimated at $155.0M based on funding round data.
Can I buy 9amHealth stock?
9amHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 9amHealth's last funding round?
9amHealth's most recent funding round was Series B on May 13, 2026.
Who are the main investors in 9amHealth?
Key investors in 9amHealth include Human Capital, Define Ventures, 7wire Ventures, Cigna Investments, Define Ventures.
Will 9amHealth IPO soon?
No public IPO plans have been announced for 9amHealth.
How can I track 9amHealth secondary market activity?
Caplight tracks bids, offers, and trades in 9amHealth's shares on secondary markets.